Boston International Partners

Boston International Partners LLC is a privately held strategic advisory firm headquartered in Boston, Massachusetts, specializing in scientific commercialization, AI-enabled healthcare innovation, business strategy, investment advisory, and international market expansion for the life sciences, biotechnology, precision medicine, and in vitro diagnostics (IVD) industries.
 

Founded in 2021, the firm combines deep knowledge of the U.S. healthcare ecosystem with extensive experience supporting innovative biotechnology companies, diagnostic developers, research institutions, healthcare organizations, and investors across North America, Europe, and the Asia-Pacific region.
 

We help emerging and established life science companies transform scientific breakthroughs into clinical adoption and commercial success. Our work focuses on commercialization strategy, AI-driven healthcare solutions, clinical and academic collaboration development, key opinion leader (KOL) engagement, market positioning, reimbursement strategy, and navigation of the complex regulatory and business environment of North America.
 

Boston International Partners serves as a trusted commercialization partner for organizations seeking to establish a U.S. presence, expand strategic partnerships, validate new technologies, and accelerate sustainable growth through compliant, evidence-driven, and data-informed commercialization strategies.
 

Our expertise extends beyond traditional business consulting to encompass the full scientific commercialization pathway—from innovation assessment and clinical validation planning to AI-enabled workflow integration, partnership development, investment evaluation, and long-term corporate growth. By connecting industry, academia, healthcare providers, and investors, we enable our clients to translate advanced health technologies into meaningful clinical impact and durable commercial success.